Seung Ro Han

Seung Ro Han

Auto-generated profile, based on publicly available information

Seung Ro Han

Eulji Biomedical Science Research Institute, Eulji University School of Medicine, Daejeon, Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2021 in Cell Reports
Verified
Journal Article
Open access
DKDong-Min Kim
Dong-Min Kim
YKYuri Kim
Yuri Kim
JSJun-Won Seo
Jun-Won Seo
JLJooyeon Lee
Jooyeon Lee
UPUni Park
Uni Park
NCNam-Hyuk Cho
Nam-Hyuk Cho
Despite the worldwide effect of the coronavirus disease 2019 (COVID-19) pandemic, the underlying mechanisms of fatal viral pneumonia remain elusive. Here, we show that critical COVID-19 is associated with enhanced eosinophil-mediated inflammation when compared to non-critical cases. In addition, we confirm increased T helper (Th)2-biased adaptive immune responses, accompanying overt complement activation, in the critical group. Moreover, enhanced antibody responses and complement activation are associated with disease pathogenesis as evidenced by formation of immune complexes and membrane attack complexes in airways and vasculature of lung biopsies from six fatal cases, as well as by enhanced hallmark gene set signatures of Fcγ receptor (FcγR) signaling and complement activation in myeloid cells of respiratory specimens from critical COVID-19 patients. These results suggest that SARS-CoV-2 infection may drive specific innate immune responses, including eosinophil-mediated inflammation, and subsequent pulmonary pathogenesis via enhanced Th2-biased immune responses, which might be crucial drivers of critical disease in COVID-19 patients.

26 August 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SPSang-Jin Park
Sang-Jin Park
SHSeung Ro Han
Seung Ro Han
YKYun Hee Kang
Yun Hee Kang
ELEun-Jin Lee
Eun-Jin Lee
EKEu-Gene Kim
Eu-Gene Kim
DSDae-Young Song
Dae-Young Song
Purpose: Magnetic particle imaging (MPI) is an emerging radiation-free, non-invasive three-dimensional tomographic technology that can visualize the concentrations of superparamagnetic iron oxide nanoparticles (SPIONs). To verify the applicability of the previously proposed point-of-care testing MPI (PoCT-MPI) in medical diagnosis and therapeutics, we imaged SPIONs in animal tumor models. Methods: CT26 or MC38 mouse colon carcinoma cells (2 × 106 cells) were subcutaneously injected into the right flank of BALB/c mice. SPIONs were either injected directly into the tumor lesions in the intratumoral group or through tail veins in the intravenous group. CT26 and MC38 tumor models were examined both intratumorally and intravenously to confirm the biological availability of SPIONs using PoCT-MPI. Results: Signals were observed in the tumor lesions from day 1 to day 7. This is the first study to successfully image the pathological region and show the biodistribution of SPIONs in CT26 tumor models using the recently developed PoCT-MPI technology. Furthermore, MC38 tumor models were examined, resulting in similar images to those of the CT26 tumor model in both intratumoral and intravenous groups. Conclusion: The present study demonstrates the biological applicability of PoCT-MPI, which promises to be a powerful diagnostic and therapeutic technique in biomedical imaging.

20 October 2021 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
HKHong Seok Kim
Hong Seok Kim
YKYun Hee Kang
Yun Hee Kang
JLJisu Lee
Jisu Lee
SHSeung Ro Han
Seung Ro Han
DKDa Bin Kim
Da Bin Kim
Myung-Shin LeeMyung-Shin Lee
Myung-Shin Lee
Hong Seok Kim, Yun Hee Kang, Jisu Lee, Seung Ro Han, Da Bin Kim, Haeun Ko, Seyoun Park, and Myung-Shin Lee. Mol. Cells 2021;44:710-22. https://doi.org/10.14348/molcells.2021.0093